Commonwealth Equity Services’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76K | Sell |
59,964
-1,340
| -2% | -$1.7K | ﹤0.01% | 4104 |
|
|
2025
Q1 | $56K | Buy |
61,304
+3,188
| +5% | +$2.91K | ﹤0.01% | 4054 |
|
|
2024
Q4 | $92K | Buy |
58,116
+858
| +1% | +$1.36K | ﹤0.01% | 3923 |
|
|
2024
Q3 | $112K | Buy |
57,258
+1,107
| +2% | +$2.17K | ﹤0.01% | 3843 |
|
|
2024
Q2 | $92K | Buy |
56,151
+6,621
| +13% | +$10.8K | ﹤0.01% | 3824 |
|
|
2024
Q1 | $255K | Sell |
49,530
-605
| -1% | -$3.12K | ﹤0.01% | 3422 |
|
|
2023
Q4 | $287K | Buy |
50,135
+18,435
| +58% | +$106K | ﹤0.01% | 3216 |
|
|
2023
Q3 | $152K | Buy |
31,700
+150
| +0.5% | +$719 | ﹤0.01% | 3474 |
|
|
2023
Q2 | $134K | Buy |
31,550
+7,175
| +29% | +$30.5K | ﹤0.01% | 3519 |
|
|
2023
Q1 | $129 | Buy |
24,375
+2,100
| +9% | +$11 | ﹤0.01% | 3439 |
|
|
2022
Q4 | $139K | Sell |
22,275
-100
| -0.4% | -$624 | ﹤0.01% | 3344 |
|
|
2022
Q3 | $236K | Buy |
22,375
+6,135
| +38% | +$64.7K | ﹤0.01% | 3027 |
|
|
2022
Q2 | $88K | Buy |
+16,240
| New | +$88K | ﹤0.01% | 3397 |
|